| ABIOMED develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily assisting the pumping function of the heart. Co.'s products include: Impella 2.5®, which is a percutaneous micro heart pump with an integrated motor and sensors; Impella CP®, which provides more blood flow than the Impella 2.5; Impella RP®, which is a percutaneous catheter-based axial flow pump; and Impella Connect®, which is a cloud-based technology that enables remote viewing of the Automated Impella Controller for physicians and hospital staff from anywhere with internet connectivity. The ABMD stock yearly return is shown above.
The yearly return on the ABMD stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ABMD annual return calculation with any dividends reinvested as applicable (on ex-dates).